C07D 473/30
Attached in position 6
Official title: attached in position 6, e.g. hypoxanthine
C07D473/30 (Attached in position 6) appears on 219 US grants and 219 published applications in this corpus.
Search patents in C07D- Granted patents
- 219
- Published applications
- 219
- Assignees
- 156
- Inventors
- 779
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 0 |
| 2002 | 3 | 5 |
| 2003 | 7 | 5 |
| 2004 | 4 | 10 |
| 2005 | 3 | 6 |
| 2006 | 6 | 15 |
| 2007 | 3 | 6 |
| 2008 | 1 | 4 |
| 2009 | 6 | 15 |
| 2010 | 7 | 13 |
| 2011 | 5 | 5 |
| 2012 | 11 | 12 |
| 2013 | 10 | 12 |
| 2014 | 10 | 6 |
| 2015 | 9 | 9 |
| 2016 | 7 | 15 |
| 2017 | 10 | 10 |
| 2018 | 9 | 11 |
| 2019 | 11 | 10 |
| 2020 | 9 | 13 |
| 2021 | 4 | 5 |
| 2022 | 6 | 8 |
| 2023 | 6 | 7 |
| 2024 | 7 | 3 |
| 2025 | 7 | 9 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- POLQ inhibitors16 Jun 2026US 12,653,828 B2AstraZeneca AB
- Polymeric disinfectants and uses thereof17 Feb 2026US 12,552,882 B2Technion Research & Development Foundation Limited
- Substituted tetrazoles as TRPA1 inhibitors16 Dec 2025US 12,497,401 B2Boehringer Ingelheim International GmbH
- Salicyl-adenosinemonosulfamate analogs and uses thereof7 Oct 2025US 12,435,088 B2Memorial Sloan Kettering Cancer Center
- POLQ inhibitors16 Sep 2025US 12,414,954 B2AstraZeneca AB
- Substituted pyridinone compounds and uses thereof1 Oct 2026US 2026/0294879 A1Pfizer Inc.
- Polq inhibitors24 Sep 2026US 2026/0284059 A1AstraZeneca AB
- Non-covalent dimer cation of purine/pyrimidine and amino acid, salt thereof, preparation method therefor, and use thereof13 Aug 2026US 2026/0234153 A1Suzhou Protonation Chain Biotechnology Co., Ltd
- Heterocyclic Compounds as ENT Inhibitors and Compounds for Use in the Treatment of Cancers2 Jul 2026US 2026/0184712 A1iTeos Belgium SA
- Novel compounds and uses thereof21 May 2026US 2026/0138956 A1Recursion Pharmaceuticals, Inc.
Most cited
By later US patents
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- Purine derivative193US 6,028,076 AJapan Energy Corporation · 2000
- Inhibitors of human phosphatidylinositol 3-kinase delta181US 6,518,277 B1ICOS Corporation · 2003
- Inhibitors of human phosphatidylinositol 3-kinase delta145US 6,800,620 B2ICOS Corporation · 2004
- Purine derivatives and medicaments comprising the same as active ingredient142US 6,734,187 B1Mitsubishi Chemical Corporation · 2004